STAT3 also promotes tumor progression and immune evasion by driving tumor cell resistance to natural killer (NK) cell-mediated killing while also regulating NK cell functions, making it a critical target for improving NK cell-based cancer immunotherapies [47]. The gene discussed is STAT3; the disease is neoplasm.